- Home
- TRC vs CYRX Comparison
TRC vs CYRX Comparison
Compare TRC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRC
- CYRX
- Stock Information
- Founded
- TRC 1843
- CYRX 1999
- Country
- TRC United States
- CYRX United States
- Employees
- TRC N/A
- CYRX N/A
- Industry
- TRC Real Estate
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- TRC Finance
- CYRX Health Care
- Exchange
- TRC Nasdaq
- CYRX Nasdaq
- Market Cap
- TRC 455.3M
- CYRX 405.4M
- IPO Year
- TRC N/A
- CYRX N/A
- Fundamental
- Price
- TRC $15.59
- CYRX $6.52
- Analyst Decision
- TRC
- CYRX Buy
- Analyst Count
- TRC 0
- CYRX 7
- Target Price
- TRC N/A
- CYRX $13.14
- AVG Volume (30 Days)
- TRC 89.5K
- CYRX 436.3K
- Earning Date
- TRC 11-07-2024
- CYRX 11-07-2024
- Dividend Yield
- TRC N/A
- CYRX N/A
- EPS Growth
- TRC N/A
- CYRX N/A
- EPS
- TRC N/A
- CYRX N/A
- Revenue
- TRC $40,118,000.00
- CYRX $226,113,000.00
- Revenue This Year
- TRC N/A
- CYRX $0.34
- Revenue Next Year
- TRC $18.51
- CYRX $8.47
- P/E Ratio
- TRC N/A
- CYRX N/A
- Revenue Growth
- TRC N/A
- CYRX N/A
- 52 Week Low
- TRC $14.80
- CYRX $5.32
- 52 Week High
- TRC $19.82
- CYRX $20.11
- Technical
- Relative Strength Index (RSI)
- TRC 39.36
- CYRX 37.93
- Support Level
- TRC $15.92
- CYRX $7.18
- Resistance Level
- TRC $17.46
- CYRX $8.79
- Average True Range (ATR)
- TRC 0.46
- CYRX 0.62
- MACD
- TRC -0.06
- CYRX -0.11
- Stochastic Oscillator
- TRC 3.05
- CYRX 8.47
About TRC Tejon Ranch Co
Tejon Ranch Co is a diversified real estate development and agribusiness company committed to responsibly using its land and resources to meet the housing, employment, and lifestyle needs of Californians and create value for its shareholders. It has five segments namely commercial/industrial real estate development, resort/residential real estate development, mineral resources, farming, and ranch operations.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.